The purpose of this study was to develop a syngeneic metastatic model of pancreatic cancer cachexia and to investigate immunotherapeutic treatment strategies, including TLR 7/9 blockade and TGF-β blockade. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.